SCHEDULE 13D/A
SCHEDULE 13D/ASchedule 13D ownership disclosure
Cognition Therapeutics Inc
Common Stock, par value $0.001 per share · CUSIP: 19243B102
Event date: 2025-09-19
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BIOS MEMORY SPV I, LPReported CIK 0001643749
Shares: 1,424,014.00 · Class: 1.6%
- BIOS MEMORY SPV II, LPReported CIK 0001666485
Shares: 385,248.00 · Class: 0.4%
- BIOS FUND I, LPReported CIK 0001697316
Shares: 418,926.00 · Class: 0.5%
- BIOS FUND I QP, LPReported CIK 0001700297
Shares: 245,029.00 · Class: 0.3%
- BP DIRECTORS, LPReported CIK 0001813311
Shares: 32,328.00 · Class: 0.04%
- BIOS FUND II, LPReported CIK 0001714576
Shares: 78,298.00 · Class: 0.1%
- BIOS FUND II QP, LPReported CIK 0001716869
Shares: 255,765.00 · Class: 0.3%
- BIOS FUND II NT, LPReported CIK 0001728851
Shares: 34,238.00 · Class: 0.04%
- BIOS FUND III, LPReported CIK 0001791917
Shares: 309,748.00 · Class: 0.4%
- BIOS FUND III QP, LPReported CIK 0001791916
Shares: 2,021,906.00 · Class: 2.3%
- BIOS FUND III NT, LPReported CIK 0001791910
Shares: 326,733.00 · Class: 0.4%
- BIOS CLINICAL OPPORTUNITY FUND, LPReported CIK 0001988639
Shares: 500,095.00 · Class: 0.6%
- BIOS EQUITY PARTNERS, LPReported CIK 0001813314
Shares: 1,081,531.00 · Class: 1.2%
- BIOS EQUITY PARTNERS II, LPReported CIK 0001813313
Shares: 368,301.00 · Class: 0.4%
- BIOS EQUITY PARTNERS III, LPReported CIK 0001831976
Shares: 2,658,387.00 · Class: 3.0%
- BIOS EQUITY COF, LPReported CIK 0002000747
Shares: 500,095.00 · Class: 0.6%
- CAVU MANAGEMENT, LPReported CIK 0001813270
Shares: 5,532,233.00 · Class: 6.3%
- BIOS CAPITAL MANAGEMENT, LPReported CIK 0001813845
Shares: 6,032,328.00 · Class: 6.8%
- CAVU ADVISORS, LLCReported CIK 0001813310
Shares: 5,532,233.00 · Class: 6.3%
- BIOS ADVISORS GP, LLCReported CIK 0001813844
Shares: 6,032,328.00 · Class: 6.8%
- LESLIE W. KREISReported CIK 0001813316
Shares: 5,532,233.00 · Class: 6.3%
- AARON G.L. FLETCHERReported CIK 0001789490
Shares: 6,059,555.00 · Class: 6.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-092675
- Form type
- SCHEDULE 13D/A
- Filer
- BIOS Memory SPV I, LP
- CIK
- CIK 1643749
- Filed
- Sep 23, 2025
- Reporting period
- Sep 19, 2025
- Description
- Schedule 13D beneficial ownership